• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓样细胞分化因子(Myeloid NEMO)缺陷通过单核细胞趋化蛋白 1-CC 趋化因子受体 2(MCP1-CCR2)轴促进肿瘤免疫抑制。

Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.

机构信息

Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China; Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, People's Republic of China.

Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China; Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, People's Republic of China; Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, 050000, People's Republic of China.

出版信息

Exp Cell Res. 2021 Feb 15;399(2):112467. doi: 10.1016/j.yexcr.2020.112467. Epub 2021 Jan 8.

DOI:10.1016/j.yexcr.2020.112467
PMID:33428904
Abstract

Tumor-associated macrophages (TAM), which are found in the tumor microenvironment of solid tumors, not only mediate cancer immune evasion but also promote tumor growth. The transcription factor NF-κB, which is a crucial link between inflammation and tumors, can accelerate tumor occurrence and development. NEMO, the regulatory subunit of the IKK complex, plays a pivotal role in activating the NF-κB signaling pathway. However, the function of myeloid NEMO in the tumor microenvironment remains unclear. Here, we found that conditional knockout of NEMO in myeloid cells promoted tumor growth in a transplanted cancer mouse model. In Nemo lyz-cre mice, the deletion of Nemo in myeloid cells increased the recruitment of M2 macrophages and myeloid-derived suppressor cells (MDSCs) into the tumor, reduced the expression of apoptosis-related proteins, and upregulated the expression of the chemokine receptor CCR2, thereby promoting tumor growth in vivo. Then, we showed that blocking the MCP1-CCR2 pathway could inhibit tumor growth, especially in mice with myeloid NEMO deletion. In this study, we examined the mechanism of NEMO in myeloid cells and explored the role of NEMO in the prevention and treatment of cancer.

摘要

肿瘤相关巨噬细胞(TAM)存在于实体瘤的肿瘤微环境中,不仅介导癌症免疫逃逸,还促进肿瘤生长。转录因子 NF-κB 是炎症与肿瘤之间的关键环节,它可以加速肿瘤的发生和发展。IKK 复合物的调节亚基 NEMO 在激活 NF-κB 信号通路中起着关键作用。然而,髓系细胞中 NEMO 的功能在肿瘤微环境中尚不清楚。在这里,我们发现髓系细胞中 NEMO 的条件性缺失促进了移植癌症小鼠模型中的肿瘤生长。在 Nemo lyz-cre 小鼠中,髓系细胞中 Nemo 的缺失增加了 M2 巨噬细胞和髓源性抑制细胞(MDSCs)向肿瘤的募集,降低了凋亡相关蛋白的表达,并上调了趋化因子受体 CCR2 的表达,从而促进了体内肿瘤的生长。然后,我们表明阻断 MCP1-CCR2 通路可以抑制肿瘤生长,特别是在髓系 NEMO 缺失的小鼠中。在这项研究中,我们研究了 NEMO 在髓系细胞中的作用机制,并探索了 NEMO 在癌症预防和治疗中的作用。

相似文献

1
Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.髓样细胞分化因子(Myeloid NEMO)缺陷通过单核细胞趋化蛋白 1-CC 趋化因子受体 2(MCP1-CCR2)轴促进肿瘤免疫抑制。
Exp Cell Res. 2021 Feb 15;399(2):112467. doi: 10.1016/j.yexcr.2020.112467. Epub 2021 Jan 8.
2
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.CCR2 抑制减少肿瘤髓系细胞,并揭示检查点抑制剂的作用以减缓耐药性小鼠脑胶质瘤的进展。
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1129-1138. doi: 10.1073/pnas.1910856117. Epub 2019 Dec 26.
3
Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.NEMO 特异性缺失小鼠肝实质细胞中 CCR2 和 CCR5 对肝巨噬细胞极化的作用。
Cell Mol Gastroenterol Hepatol. 2021;11(2):327-347. doi: 10.1016/j.jcmgh.2020.08.012. Epub 2020 Sep 4.
4
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.CCL2/CCR2通路介导髓系抑制细胞向癌症部位募集。
Cancer Lett. 2007 Jul 8;252(1):86-92. doi: 10.1016/j.canlet.2006.12.012. Epub 2007 Jan 25.
5
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2/CX3CR1 M-MDSCs into the tumor microenvironment in a redundant manner.胶质母细胞瘤衍生的 CCL2 和 CCL7 以冗余方式介导免疫抑制性 CCR2/CX3CR1 M-MDSC 向肿瘤微环境迁移。
Front Immunol. 2023 Jan 4;13:993444. doi: 10.3389/fimmu.2022.993444. eCollection 2022.
6
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.使用CCL2中和抗体阻断CCL2-CCR2轴是小鼠模型中肝细胞癌的有效治疗方法。
Mol Cancer Ther. 2017 Feb;16(2):312-322. doi: 10.1158/1535-7163.MCT-16-0124. Epub 2016 Dec 15.
7
Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.单核细胞 CCR2(+) 髓系来源抑制细胞通过限制激活的 CD8 T 细胞浸润到肿瘤微环境中促进免疫逃逸。
Cancer Res. 2012 Feb 15;72(4):876-86. doi: 10.1158/0008-5472.CAN-11-1792. Epub 2011 Dec 15.
8
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?靶向 CCL2/CCR2 轴在癌症免疫治疗中的应用:一石三鸟?
Front Immunol. 2021 Nov 3;12:771210. doi: 10.3389/fimmu.2021.771210. eCollection 2021.
9
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.通过 CCL2/CCR2 信号靶向肿瘤浸润巨噬细胞作为一种治疗肝细胞癌的策略。
Gut. 2017 Jan;66(1):157-167. doi: 10.1136/gutjnl-2015-310514. Epub 2015 Oct 9.
10
Monocytic myeloid-derived suppressor cells home to tumor-draining lymph nodes via CCR2 and locally modulate the immune response.单核细胞来源的髓样抑制细胞通过 CCR2 归巢至肿瘤引流淋巴结,并在局部调节免疫反应。
Cell Immunol. 2021 Apr;362:104296. doi: 10.1016/j.cellimm.2021.104296. Epub 2021 Jan 30.